Plasma Fractionation Market 2027 by Types, Application, Technology, Opportunities, End Users and Regions | The Insight Partners

Plasma Fractionation Market to 2027 - Global Analysis and Forecasts By Product ( Immunoglobulin, Albumin, Coagulation Factor Concentrates, Protease Inhibitors and Other Plasma Products ); Application ( Neurology, Immunology, Hematology, Critical Care, Pulmonology and Other Applications ); End User ( Hospitals and Clinics, Clinical Research Laboratories, Academic Institutes and Other End Users ) and Geography

Report Code: TIPRE00003422 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming
MARKET INTRODUCTION
Plasma fractionation is a process of separating various components of blood plasma. The separated components are used for producing different therapeutic plasma products, which are capable of treating different medical conditions. Some of the commonly used plasma products are, immune globins, coagulation factors, abumins as well as inhibitors such as, Alpha-1 antitrypsin (AAT) or Alpha-1 Proteinase Inhibitor (A1PI), Antithrombin III (AT-III) and C1 Esterase Inhibitor (C1-INH).

MARKET DYNAMICS
The plasma fractionation market is anticipated to grow in the forecast period owing to driving factors such as growing use of immunoglobulins in medical field and growing prevalence of chronic diseases. In addition, growing number of individuals with hemophilia are expected to offer significant growth opportunities in the market during the forecast period.

MARKET SCOPE
The "Global Plasma Fractionation Market Analysis to 2027" is a specialized and in-depth study of the pharmaceutical industry with a special focus on the global market trend analysis. The report aims to provide an overview of plasma fractionation market with detailed market segmentation by product, application, end user and geography. The global plasma fractionation market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading plasma fractionation market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION
The global plasma fractionation market is segmented on the basis of product, application and end user. Based on product, the market is segmented immunoglobulin, albumin, coagulation factor concentrates, protease inhibitors and other plasma products. The plasma fractionation market, based on application is segmented into, neurology, immunology, hematology, critical care, pulmonology and other applications. On the basis of end user, the global plasma fractionation market is segmented into, hospitals and clinics, clinical research laboratories, academic institutes and other end users.


REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global plasma fractionation market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The plasma fractionation market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting plasma fractionation market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the plasma fractionation market in these regions.


MARKET PLAYERS

The reports cover key developments in the plasma fractionation market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market payers from plasma fractionation market are anticipated to lucrative growth opportunities in the future with the rising demand for plasma fractionation market in the global market. Below mentioned is the list of few companies engaged in the plasma fractionation market.

The report also includes the profiles of key plasma fractionation market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

• Bio Products Laboratory Ltd.
• Biotest AG
• China Biologic Products Holdings, Inc.
• CSL Limited
• GREEN CROSS CORP
• Grifols S.A.
• Kedrion S.p.A
• Octapharma
• PlasmaGen Biosciences Pvt. Ltd.
• Sanquin

The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.
TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Plasma Fractionation Market - By Product
1.3.2 Plasma Fractionation Market - By Application
1.3.3 Plasma Fractionation Market - By End User
1.3.4 Plasma Fractionation Market - By Region
1.3.4.1 By Country

2. KEY TAKEWAYS

3. RESEARCH METHODOLOGY

4. PLASMA FRACTIONATION MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS

5. PLASMA FRACTIONATION MARKET - KEY MARKET DYNAMICS

5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. PLASMA FRACTIONATION MARKET - GLOBAL MARKET ANALYSIS
6.1. PLASMA FRACTIONATION - GLOBAL MARKET OVERVIEW
6.2. PLASMA FRACTIONATION - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE

7. PLASMA FRACTIONATION MARKET - REVENUE AND FORECASTS TO 2027 - PRODUCT
7.1. OVERVIEW
7.2. PRODUCT MARKET FORECASTS AND ANALYSIS
7.3. IMMUNOGLOBULIN
7.3.1. Overview
7.3.2. Immunoglobulin Market Forecast and Analysis
7.3.3. Intravenous Immunoglobulin (IVIG) Market
7.3.3.1. Overview
7.3.3.2. Intravenous Immunoglobulin (IVIG) Market Forecast and Analysis
7.3.4. Subcutaneous Immunoglobulin (SCIG) Market
7.3.4.1. Overview
7.3.4.2. Subcutaneous Immunoglobulin (SCIG) Market Forecast and Analysis
7.3.5. Other Immunoglobulins Market
7.3.5.1. Overview
7.3.5.2. Other Immunoglobulins Market Forecast and Analysis
7.4. ALBUMIN
7.4.1. Overview
7.4.2. Albumin Market Forecast and Analysis
7.5. COAGULATION FACTOR CONCENTRATES
7.5.1. Overview
7.5.2. Coagulation Factor Concentrates Market Forecast and Analysis
7.6. PROTEASE INHIBITORS
7.6.1. Overview
7.6.2. Protease Inhibitors Market Forecast and Analysis
7.7. OTHER PLASMA PRODUCTS
7.7.1. Overview
7.7.2. Other Plasma Products Market Forecast and Analysis

8. PLASMA FRACTIONATION MARKET - REVENUE AND FORECASTS TO 2027 - APPLICATION
8.1. OVERVIEW
8.2. APPLICATION MARKET FORECASTS AND ANALYSIS
8.3. NEUROLOGY
8.3.1. Overview
8.3.2. Neurology Market Forecast and Analysis
8.4. IMMUNOLOGY
8.4.1. Overview
8.4.2. Immunology Market Forecast and Analysis
8.5. HEMATOLOGY
8.5.1. Overview
8.5.2. Hematology Market Forecast and Analysis
8.6. CRITICAL CARE
8.6.1. Overview
8.6.2. Critical Care Market Forecast and Analysis
8.7. PULMONOLOGY
8.7.1. Overview
8.7.2. Pulmonology Market Forecast and Analysis
8.8. OTHER APPLICATIONS
8.8.1. Overview
8.8.2. Other Applications Market Forecast and Analysis

9. PLASMA FRACTIONATION MARKET - REVENUE AND FORECASTS TO 2027 - END USER

9.1. OVERVIEW
9.2. END USER MARKET FORECASTS AND ANALYSIS
9.3. HOSPITALS AND CLINICS
9.3.1. Overview
9.3.2. Hospitals and Clinics Market Forecast and Analysis
9.4. CLINICAL RESEARCH LABORATORIES
9.4.1. Overview
9.4.2. Clinical Research Laboratories Market Forecast and Analysis
9.5. ACADEMIC INSTITUTES
9.5.1. Overview
9.5.2. Academic Institutes Market Forecast and Analysis
9.6. OTHER END USERS
9.6.1. Overview
9.6.2. Other End Users Market Forecast and Analysis

10. PLASMA FRACTIONATION MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Plasma Fractionation Market Overview
10.1.2 North America Plasma Fractionation Market Forecasts and Analysis
10.1.3 North America Plasma Fractionation Market Forecasts and Analysis - By Product
10.1.4 North America Plasma Fractionation Market Forecasts and Analysis - By Application
10.1.5 North America Plasma Fractionation Market Forecasts and Analysis - By End User
10.1.6 North America Plasma Fractionation Market Forecasts and Analysis - By Countries
10.1.6.1 United States Plasma Fractionation Market
10.1.6.1.1 United States Plasma Fractionation Market by Product
10.1.6.1.2 United States Plasma Fractionation Market by Application
10.1.6.1.3 United States Plasma Fractionation Market by End User
10.1.6.2 Canada Plasma Fractionation Market
10.1.6.2.1 Canada Plasma Fractionation Market by Product
10.1.6.2.2 Canada Plasma Fractionation Market by Application
10.1.6.2.3 Canada Plasma Fractionation Market by End User
10.1.6.3 Mexico Plasma Fractionation Market
10.1.6.3.1 Mexico Plasma Fractionation Market by Product
10.1.6.3.2 Mexico Plasma Fractionation Market by Application
10.1.6.3.3 Mexico Plasma Fractionation Market by End User
10.2. EUROPE
10.2.1 Europe Plasma Fractionation Market Overview
10.2.2 Europe Plasma Fractionation Market Forecasts and Analysis
10.2.3 Europe Plasma Fractionation Market Forecasts and Analysis - By Product
10.2.4 Europe Plasma Fractionation Market Forecasts and Analysis - By Application
10.2.5 Europe Plasma Fractionation Market Forecasts and Analysis - By End User
10.2.6 Europe Plasma Fractionation Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Plasma Fractionation Market
10.2.6.1.1 Germany Plasma Fractionation Market by Product
10.2.6.1.2 Germany Plasma Fractionation Market by Application
10.2.6.1.3 Germany Plasma Fractionation Market by End User
10.2.6.2 France Plasma Fractionation Market
10.2.6.2.1 France Plasma Fractionation Market by Product
10.2.6.2.2 France Plasma Fractionation Market by Application
10.2.6.2.3 France Plasma Fractionation Market by End User
10.2.6.3 Italy Plasma Fractionation Market
10.2.6.3.1 Italy Plasma Fractionation Market by Product
10.2.6.3.2 Italy Plasma Fractionation Market by Application
10.2.6.3.3 Italy Plasma Fractionation Market by End User
10.2.6.4 Spain Plasma Fractionation Market
10.2.6.4.1 Spain Plasma Fractionation Market by Product
10.2.6.4.2 Spain Plasma Fractionation Market by Application
10.2.6.4.3 Spain Plasma Fractionation Market by End User
10.2.6.5 United Kingdom Plasma Fractionation Market
10.2.6.5.1 United Kingdom Plasma Fractionation Market by Product
10.2.6.5.2 United Kingdom Plasma Fractionation Market by Application
10.2.6.5.3 United Kingdom Plasma Fractionation Market by End User
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Plasma Fractionation Market Overview
10.3.2 Asia-Pacific Plasma Fractionation Market Forecasts and Analysis
10.3.3 Asia-Pacific Plasma Fractionation Market Forecasts and Analysis - By Product
10.3.4 Asia-Pacific Plasma Fractionation Market Forecasts and Analysis - By Application
10.3.5 Asia-Pacific Plasma Fractionation Market Forecasts and Analysis - By End User
10.3.6 Asia-Pacific Plasma Fractionation Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Plasma Fractionation Market
10.3.6.1.1 Australia Plasma Fractionation Market by Product
10.3.6.1.2 Australia Plasma Fractionation Market by Application
10.3.6.1.3 Australia Plasma Fractionation Market by End User
10.3.6.2 China Plasma Fractionation Market
10.3.6.2.1 China Plasma Fractionation Market by Product
10.3.6.2.2 China Plasma Fractionation Market by Application
10.3.6.2.3 China Plasma Fractionation Market by End User
10.3.6.3 India Plasma Fractionation Market
10.3.6.3.1 India Plasma Fractionation Market by Product
10.3.6.3.2 India Plasma Fractionation Market by Application
10.3.6.3.3 India Plasma Fractionation Market by End User
10.3.6.4 Japan Plasma Fractionation Market
10.3.6.4.1 Japan Plasma Fractionation Market by Product
10.3.6.4.2 Japan Plasma Fractionation Market by Application
10.3.6.4.3 Japan Plasma Fractionation Market by End User
10.3.6.5 South Korea Plasma Fractionation Market
10.3.6.5.1 South Korea Plasma Fractionation Market by Product
10.3.6.5.2 South Korea Plasma Fractionation Market by Application
10.3.6.5.3 South Korea Plasma Fractionation Market by End User
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Plasma Fractionation Market Overview
10.4.2 Middle East and Africa Plasma Fractionation Market Forecasts and Analysis
10.4.3 Middle East and Africa Plasma Fractionation Market Forecasts and Analysis - By Product
10.4.4 Middle East and Africa Plasma Fractionation Market Forecasts and Analysis - By Application
10.4.5 Middle East and Africa Plasma Fractionation Market Forecasts and Analysis - By End User
10.4.6 Middle East and Africa Plasma Fractionation Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Plasma Fractionation Market
10.4.6.1.1 South Africa Plasma Fractionation Market by Product
10.4.6.1.2 South Africa Plasma Fractionation Market by Application
10.4.6.1.3 South Africa Plasma Fractionation Market by End User
10.4.6.2 Saudi Arabia Plasma Fractionation Market
10.4.6.2.1 Saudi Arabia Plasma Fractionation Market by Product
10.4.6.2.2 Saudi Arabia Plasma Fractionation Market by Application
10.4.6.2.3 Saudi Arabia Plasma Fractionation Market by End User
10.4.6.3 U.A.E Plasma Fractionation Market
10.4.6.3.1 U.A.E Plasma Fractionation Market by Product
10.4.6.3.2 U.A.E Plasma Fractionation Market by Application
10.4.6.3.3 U.A.E Plasma Fractionation Market by End User
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Plasma Fractionation Market Overview
10.5.2 South and Central America Plasma Fractionation Market Forecasts and Analysis
10.5.3 South and Central America Plasma Fractionation Market Forecasts and Analysis - By Product
10.5.4 South and Central America Plasma Fractionation Market Forecasts and Analysis - By Application
10.5.5 South and Central America Plasma Fractionation Market Forecasts and Analysis - By End User
10.5.6 South and Central America Plasma Fractionation Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Plasma Fractionation Market
10.5.6.1.1 Brazil Plasma Fractionation Market by Product
10.5.6.1.2 Brazil Plasma Fractionation Market by Application
10.5.6.1.3 Brazil Plasma Fractionation Market by End User
10.5.6.2 Argentina Plasma Fractionation Market
10.5.6.2.1 Argentina Plasma Fractionation Market by Product
10.5.6.2.2 Argentina Plasma Fractionation Market by Application
10.5.6.2.3 Argentina Plasma Fractionation Market by End User

11. INDUSTRY LANDSCAPE

11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS

12. PLASMA FRACTIONATION MARKET, KEY COMPANY PROFILES

12.1. BIO PRODUCTS LABORATORY LTD.
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. BIOTEST AG
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. CHINA BIOLOGIC PRODUCTS HOLDINGS, INC.
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. CSL LIMITED
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. GREEN CROSS CORP
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. GRIFOLS S.A.
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. KEDRION S.P.A
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. OCTAPHARMA
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. PLASMAGEN BIOSCIENCES PVT. LTD.
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. SANQUIN
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments

13. APPENDIX

13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
The List of Companies

1. Bio Products Laboratory Ltd.
2. Biotest AG
3. China Biologic Products Holdings, Inc.
4. CSL Limited
5. GREEN CROSS CORP
6. Grifols S.A.
7. Kedrion S.p.A
8. Octapharma
9. PlasmaGen Biosciences Pvt. Ltd.
10. Sanquin
Select License Type
USD $3000
USD $4550
USD $6550
USD $8550

Free

20%

customization on Pre-Booking
Pre Book